compound 1 [WO2012007375]   Click here for help

GtoPdb Ligand ID: 8084

Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Development of this compound is covered in patent WO2012007375 [1]. It is a potent IRAK4 inhibitor.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 3
Rotatable bonds 5
Topological polar surface area 108.78
Molecular weight 400.14
XLogP 1.94
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES NCC1CCN(CC1)c1ccc(cc1NC(=O)c1cnn2c1ncc(c2)O)Cl
Isomeric SMILES NCC1CCN(CC1)c1ccc(cc1NC(=O)c1cnn2c1ncc(c2)O)Cl
InChI InChI=1S/C19H21ClN6O2/c20-13-1-2-17(25-5-3-12(8-21)4-6-25)16(7-13)24-19(28)15-10-23-26-11-14(27)9-22-18(15)26/h1-2,7,9-12,27H,3-6,8,21H2,(H,24,28)
InChI Key BNVZRFQNZWYPQH-UHFFFAOYSA-N
Bioactivity Comments
This compound has off-target activity at IRAK1, with IC50 55nM [1].
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
interleukin 1 receptor associated kinase 4 Primary target of this compound Hs Inhibitor Inhibition 9.0 pIC50 - 1
pIC50 9.0 (IC50 1x10-9 M) [1]
interleukin 1 receptor associated kinase 1 Hs Inhibitor Inhibition 7.3 pIC50 - 1
pIC50 7.3 (IC50 5.5x10-8 M) [1]